VRCA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 121630 min ago

@ $5.55

Wydano: 13 vas. 2024 @ 17:00

Zwrot: 37.96%

Poprzedni sygnał: vas. 9 - 18:12

Poprzedni sygnał: Sprzedaż

Zwrot: 2.31 %

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 23:00):

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States...

Stats
Dzisiejszy wolumen	347 559
Średni wolumen	152 878
Kapitalizacja rynkowa	324.51M
EPS	$0 ( 2024-02-29 )
Następna data zysków	( $-0.540 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.17
ATR14	$0.0160 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Hayes Christopher G.	Buy	40 000	Common Stock
2024-03-15	Hayes Christopher G.	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Goldenberg Gary	Buy	40 000	Common Stock
2024-03-15	Goldenberg Gary	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Kohler Terry	Buy	80 000	Employee Stock Option (right to buy)

INSIDER POWER
90.82
Last 98 transactions
Buy: 14 420 498 \| Sell: 288 608

Wolumen Korelacja

Długi: -0.19 (neutral)

Krótki: -0.68 (moderate negative)

Signal:(49.751) Neutral

Verrica Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
TGTX	0.959
IDCC	0.956
SLMBP	0.955
VBOCU	0.955
RAM	0.95
WKEY	0.95
OVLY	0.948
NCAC	0.947
MESA	0.946
GPACU	0.945

10 Najbardziej negatywne korelacje
CBNK	-0.945
CYTO	-0.939
GSMG	-0.938
GNTY	-0.936
BFRI	-0.936
FGBI	-0.936
GOOD	-0.934
AMNB	-0.93
CMLS	-0.929
ALHC	-0.927

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Verrica Pharmaceuticals Korelacja - Waluta/Towar

-0.17
( neutral )

-0.26
( neutral )

0.00
( neutral )

-0.17
( neutral )

0.26
( neutral )

0.19
( neutral )

Verrica Pharmaceuticals Finanse

Annual	2023
Przychody:	$5.12M
Zysk brutto:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2023
Przychody:	$5.12M
Zysk brutto:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2022
Przychody:	$9.03M
Zysk brutto:	$8.31M (91.97 %)
EPS:	$-0.810

FY	2021
Przychody:	$12.00M
Zysk brutto:	$12.00M (100.00 %)
EPS:	$-1.300

Financial Reports:

No articles found.

Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.